Post Test and Evaluation

Please note that to receive credit you must achieve a score of at least 70%.
Certificate of Credit will be emailed within 4 weeks of successful completion of the activity.

Post-Activity Test

Question Title

1. Which of the following statements regarding OAB is least accurate?

OAB is similarly prevalent in men and women.

Incontinence associated with OAB is more prevalent in women than men.

OAB mainly impacts older adults (>60 years of age).

Less than 50% of those with OAB will discuss their condition with a healthcare provider.

Question Title

2. The most appropriate initial diagnostic test for a patient with OAB symptoms is:

Urodynamics

Urinalysis with urine culture

Post-void residual

Cystoscopy

Question Title

3. Stress incontinence must be present for an OAB diagnosis.

True

False

Question Title

4. All of the following lifestyle changes can improve OAB symptoms except:

Quit smoking

Reduce weight

Limit caffeine intake

Take a daily vitamin D supplement

Question Title

5. According to the AUA, first-line treatment of OAB is:

Behavioral therapy

Anti-muscarinic therapy

Beta3-agonist therapy

Botulinum toxin injection

Question Title

6. Behavioral therapy includes all of the following except:

Bladder training

Pelvic floor muscle training

Scheduled voiding

Home catheterization

Question Title

7. According to AUA, second-line treatment of OAB can include any of the following except:

Immediate-release antimuscarinic therapy

Extended-release antimuscarinic therapy

Beta3-agonist

Botulinum toxin injection

Question Title

8. Which of the following adverse effects is most common with antimuscarinic agent use?

Headache

Urinary tract infection

Dry mouth

Hypertension

Question Title

9. All of the following are appropriate options for a patient complaining of dry mouth while taking an antimuscarinic agent except:

Switch to another antimuscarinic agent

Increase the dose

Switch to a beta3-agonist

Encourage the use of sugar-free gum

Question Title

10. For a patient with refractory OAB who has failed behavioral therapy and treatment with an antimuscarinic agent, appropriate options include all of the following except:

Switch to a beta3-agonist or another antimuscarinic agent

Consider combination therapy

Discontinue treatment as the patient is likely nonadherent

Referral to a urologist